Key takeaways
- Write qualification criteria for each litigation before taking a single call: product or exposure, injury, dates, proof and jurisdiction.
- Screen in tiers so attorneys review only files that already meet the criteria and have records ordered.
- Product liability dominates federal MDLs: 65 of 164 pending MDL dockets in November 2026 were product liability[1].
- Federal MDLs held 204,987 pending actions in that report[2]; quality control matters because weak files cost money long after intake.
- Outreach must follow the TCPA: AI-generated voices count as artificial under the FCC's 2024 ruling, and telemarketing robocalls need prior express written consent[3].
Why mass tort intake breaks under volume
Mass tort practices take calls by the hundreds or thousands when a campaign runs. The temptation is to sign everyone quickly and sort later. That approach fills a docket with files that lack proof of use, a qualifying diagnosis or a timely claim, and each weak file costs records fees, staff hours and credibility with co-counsel and the court. Quality at intake is cheaper than cleanup later.
The federal multidistrict litigation docket shows where the volume sits. In the Judicial Panel on Multidistrict Litigation's November 2026 report, 65 of 164 pending MDL dockets were product liability matters[1], and the pending MDLs together held 204,987 actions[2]. Volumes also swing sharply: when the 3M Combat Arms earplug cases wound down, personal injury and product liability filings in US district courts fell 73% in the year ending March 31, 2025[4].
Write the criteria before the first call
Every litigation needs a one-page criteria sheet, approved by the responsible attorney and dated, that intake staff and vendors apply the same way. Update it when the litigation develops, and keep earlier versions so you know which criteria applied to which file.
| Criterion | What the sheet specifies | Example of a screening question |
|---|---|---|
| Product or exposure | Brand names, generic names, versions and time window covered | Which product did you use, and from when to when? |
| Injury | Qualifying diagnoses, and any that are excluded | Has a doctor diagnosed you with any of these conditions? |
| Timing | Diagnosis date window and order of use and injury | When were you diagnosed? Was that after you started using the product? |
| Proof | Acceptable proof of use and of diagnosis | Where did you get the product? Which pharmacy or store? Which doctor? |
| Jurisdiction and limitations | States accepted and limitation flags for review | Where did you live when you used it, and when diagnosed? |
| Exclusions | Prior representation, prior settlements, specific comorbidities | Have you signed up with another law firm about this product? |
Tiered screening
Tier 1: pre-qualify in under five minutes
Product used, qualifying injury, approximate dates, state, and whether another firm already represents the caller. Callers who do not meet the basics get a polite, clear answer and, where appropriate, a referral.
Tier 2: full intake
Detailed use history, all treating providers, pharmacies, diagnosis details, other health history the criteria require, and contact information for a family member if the caller agrees.
Tier 3: documents and authorizations
Signed medical and pharmacy record authorizations, proof of use where available, and the engagement agreement, with any co-counsel or referral arrangement disclosed as the rules require.
Tier 4: records retrieval
Order records from each provider and pharmacy, and track every request to completion.
Tier 5: attorney review
The attorney reviews the file against the criteria with records in hand, then confirms, declines or holds it for more information.
Script for tier 1: I'm going to ask a few quick questions to see whether your situation fits this case. If it doesn't, I'll tell you today, and that won't be an opinion on any other claim you may have.
Declining at scale, kindly
Most callers in a mass tort campaign will not qualify. How the firm declines them matters, both for its reputation and because some of those callers have other claims or will qualify for a later litigation. Use a short, consistent decline at tier 1 and a written decline after attorney review, stating that the firm is not taking the matter, that it is not an opinion on other possible claims, and that deadlines may apply. Keep a record of every decline with the reason code from the criteria sheet. Reason codes show quickly whether the marketing is reaching the wrong audience, for example many callers who used the product outside the covered dates.
Records collection without bottlenecks
Records drive mass tort files, and they arrive slowly. Ask for every provider and pharmacy at tier 2, not just the diagnosing doctor, and record full names, cities and approximate dates. Ask callers to photograph any pill bottles, packaging, receipts or device cards they still have, and to keep the originals. Track each records request with a date sent, a follow-up date and a status, and report weekly on requests older than your standard.
- Pharmacy records often prove use when medical records do not.
- Device cases need implant records, including lot or serial numbers where available.
- Exposure cases may need employment or residence history; ask for dates and addresses.
- Deceased claimants need estate representatives; flag them for a separate process.
Quality controls that scale
- Duplicate checks on name, date of birth and phone before a file is opened, to catch callers who signed up twice or with another firm.
- A weekly random sample of tier 2 intakes, reviewed by a senior staff member against the criteria sheet.
- Red flags for review: identical stories from several callers, unusual referral sources, or answers that change between calls.
- Call recording review for vendor and in-house intake, focused on whether staff stayed within the script.
- A rule that no file reaches attorney review without records ordered.
If an outside vendor handles any tier, the firm remains responsible for how calls are handled. Review vendor scripts, recordings and reports on the same schedule as in-house work.
Staffing and training for campaign peaks
Campaign volume is uneven. A news story, a court ruling or an ad flight can multiply calls overnight, then fall away. Plan staffing for the peak before the campaign starts:
- Train a core team on the criteria sheet and the tier 1 script, and certify each person with a short test of sample calls before they take live calls.
- Keep an overflow plan, whether trained staff from other practice areas or a vetted answering partner, with the same script and criteria.
- Set a maximum wait or callback time, and measure it daily during the peak.
- Use one intake form for every channel, so web, phone and referral leads land in the same structure.
- Hold a short daily huddle during the first two weeks to share questions callers ask and errors found in sampling.
An SI Employee such as Ava can answer overflow calls with the approved tier 1 questions and hand each call to the team with a summary, so peaks do not turn into voicemail backlogs.
Outreach and consent
Mass tort campaigns generate outbound calls and texts, and the rules are strict. In February 2024 the FCC ruled that calls made with AI-generated voices are artificial under the Telephone Consumer Protection Act, and telemarketers need prior express written consent before robocalling consumers[3]. Violations can cost $500 each, up to three times that if willful[5]. Call back only people who contacted the firm or gave proper consent, keep consent records with each file, and have the attorney review any vendor's lead source and consent language before a campaign starts. State advertising and solicitation rules for lawyers also apply.
Keeping signed clients informed
Mass tort clients often wait a long time between sign-up and any result. Silence breeds doubt, repeat calls and clients who sign with a second firm. Send a welcome message after sign-up that explains what happens next, who to contact and how often they will hear from the firm. Follow with a status update when records arrive, when attorney review is complete, and at regular intervals afterwards, even if the update is only that the litigation is ongoing. Ask clients to tell the firm about any new diagnosis, change of address or phone number, and, sadly, any death in the family that affects the claim. Record every client contact in the file so anyone on the team can answer questions consistently.
Example: one week of a campaign
Example (fictional). A firm launches intake for a product liability litigation and receives 600 inquiries in its first week. Tier 1 takes about four minutes each and qualifies 210. Tier 2 completes 160 of those, and 120 return signed authorizations by Friday. The weekly sample of 20 tier 2 files finds three where the diagnosis date was recorded before first use, a criteria failure the staff had missed; the team retrains on the timing question the same day. Records requests go out within 24 hours of each signed authorization, and the attorney review queue receives only files with records ordered.
Metrics to watch
| Metric | What it tells you |
|---|---|
| Tier 1 qualification rate | Whether marketing reaches people who fit the criteria |
| Tier 2 completion rate | Whether callers stay engaged after the first call |
| Authorization return time | Whether the paperwork process is easy enough |
| Records retrieval age | Where the bottleneck is |
| Attorney decline rate after review | Whether earlier tiers apply the criteria correctly |
| Duplicate and fraud flags | Lead source quality |
Frequently asked questions
Can intake staff tell a caller they qualify for a settlement?
No. Staff can say whether the caller meets the firm's screening criteria for review. Whether there is a claim, and what it may be worth, depends on records and the attorney's review.
Should we sign callers before records arrive?
Many firms sign at tier 3 with authorizations, then confirm or decline after attorney review with records. Tell clients plainly that the firm may decline after review.
What if the caller already signed with another firm?
Record it and do not proceed without attorney review. Contacting someone represented by another lawyer about the same matter raises ethics issues.
Can we use automated calls to follow up with leads?
Only with proper consent and attorney-approved processes. The FCC treats AI-generated voices as artificial under the TCPA, and telemarketing robocalls need prior express written consent.
References
United States Judicial Panel on Multidistrict Litigation (2026). MDL Statistics Report - Docket Type Summary (November 2, 2026) (opens in a new tab) โ
United States Judicial Panel on Multidistrict Litigation (2026). MDL Statistics Report - Distribution of Pending MDL Dockets by Actions Pending (November 2, 2026) (opens in a new tab) โ
Federal Communications Commission (2024). FCC Makes AI-Generated Voices in Robocalls Illegal (opens in a new tab) โ
United States Courts (Administrative Office of the U.S. Courts) (2025). Federal Judicial Caseload Statistics 2025 (opens in a new tab) โ
Legal Information Institute, Cornell Law School (2025). 47 U.S. Code ยง 227 - Restrictions on use of telephone equipment (opens in a new tab) โ